ENHANCING NON COMMUNICABLE DISEASE RESEARCH EXCELLENCE THROUGH ZEBRAFISH CAPACIT...
ENHANCING NON COMMUNICABLE DISEASE RESEARCH EXCELLENCE THROUGH ZEBRAFISH CAPACITY BUILDING
ZeNCure aims to foster collaborative research and enhance scientific excellence at the Institute of Molecular Genetics and Genetic Engineering, University of Belgrade (IMGGE) in Serbia. This ambitious initiative brings together IM...
ver más
30/09/2027
Líder desconocido
1M€
Presupuesto del proyecto: 1M€
Líder del proyecto
Líder desconocido
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto
el día 2024-05-13
Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.
Información adicional privada
No hay información privada compartida para este proyecto. Habla con el coordinador.
Participantes
Conecta tu I+D
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto ZeNCure
Duración del proyecto: 40 meses
Fecha Inicio: 2024-05-13
Fecha Fin: 2027-09-30
Líder del proyecto
Líder desconocido
Presupuesto del proyecto
1M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
ZeNCure aims to foster collaborative research and enhance scientific excellence at the Institute of Molecular Genetics and Genetic Engineering, University of Belgrade (IMGGE) in Serbia. This ambitious initiative brings together IMGGE with world-renowned research institutions in Germany (MPG), Portugal (CF) and the United Kingdom (UoS) along with an associated partner from Latvia (BGI RFL). The overarching goal is to elevate IMGGE's research profile by strengthening its capabilities in zebrafish (ZF) research, particularly in the context of non-communicable diseases (NCDs). NCDs pose a significant global health challenge, accounting for over 74% of all deaths worldwide. These diseases are influenced by a complex interplay of genetic, physiological, environmental, and behavioral factors. Recognizing the gravity of the situation, the EU has prioritized NCD research under the Cluster 1: Health of Horizon Europe.
ZeNCure focuses on the critical role of in vivo models in NCD research, ranging from identifying genetic and environmental risk factors to testing innovative therapeutics. It leverages cutting-edge technologies, including next-generation sequencing (NGS) and bioinformatics, to enhance IMGGE's capabilities in this field. ZeNCure is poised to accelerate the professional development of both early-stage and senior researchers, as well as administrative staff. This holistic approach will not only enhance IMGGE's competitiveness in European research funding schemes but also create an inspiring and supportive research environment.
ZeNCure represents a transformative endeavor that aims to strengthen scientific collaboration, improve research capabilities, and contribute to the global fight against NCDs. By bridging the gap between IMGGE and leading European research institutions, the project aspires to elevate IMGGE into a competitive and internationally recognized research institution in the Western Balkans, fostering regional integration and convergence with the EU.